Equity (Tables)

6 Months Ended

Dec. 31, 2022

Equity [Abstract]

Schedule of Impact on Results of Operations of Recording Stock-Based Compensation by Function

The impact on our results of operations of recording stock-based compensation by function for the periods presented was as follows (in millions):

	Three Months Ended				Six Months Ended
	December 31, 2022		January 1, 2022		December 31, 2022		January 1, 2022
Cost of sales	$	6.7	$	5.2	$	12.2	$	9.8
Research and development	10.6		5.4		20.2		10.4
Selling, general and administrative	19.3		16.7		50.8		31.9
Total stock-based compensation	$	36.6	$	27.3	$	83.2	$	52.1

Schedule of Income Tax Benefit Associated with Stock-Based Compensation

Total income tax benefit associated with stock-based compensation recognized in our condensed consolidated statements of operations during the years presented was as follows (in millions):

	Three Months Ended				Six Months Ended
	December 31, 2022		January 1, 2022		December 31, 2022		January 1, 2022
Income tax benefit associated with stock-based compensation	$	6.4	$	4.2	$	11.5	$	8.2

Schedule of Awards Activity

The following table summarizes our award activity for the three and six months ended December 31, 2022 (in millions, except per share amounts):

	Restricted Stock Units			Performance Stock Units
	Number of Shares	Weighted-Average Grant Date Fair Value per Share		Number of Shares	Weighted-Average Grant Date Fair Value per Share
Balance as of July 2, 2022	2.0	$	85.9	0.3	$	81.9
Replacement Awards Issued	0.4	93.4		—	—
Granted	1.6	86.9		0.6	88.2
Vested	(0.7)	83.9		(0.1)	70.5
Canceled	(0.2)	88.1		(0.1)	88.6
Balance as of December 31, 2022	3.1	$	87.8	0.7	$	89.3

Schedule of Awards Available for Grant

A summary of awards available for grant is as follows (in millions):

	Awards Available for Grant
Balance as of July 2, 2022	3.8
Assumed in connection with NeoPhotonics merger	0.4
Replacement Awards	(0.4)
Authorized	0.9
Granted	(2.2)
Canceled	0.3
Balance as of December 31, 2022	2.8